54 related articles for article (PubMed ID: 21632679)
1. Bosentan in clinical practice for treating digital and other ischemic ulcers in Spanish patients with systemic sclerosis: IBER-DU cohort study.
Roman Ivorra JA; Simeon CP; Alegre Sancho JJ; Egurbide MV; Castillo MJ; Lloria X; Fonollosa V
J Rheumatol; 2011 Aug; 38(8):1631-5. PubMed ID: 21632679
[TBL] [Abstract][Full Text] [Related]
2. Targeting the endothelin axis in scleroderma renal crisis: rationale and feasibility.
Penn H; Quillinan N; Khan K; Chakravarty K; Ong VH; Burns A; Denton CP
QJM; 2013 Sep; 106(9):839-48. PubMed ID: 23696678
[TBL] [Abstract][Full Text] [Related]
3. Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher/European Scleroderma Trials and Research group (EUSTAR) survey.
Blagojevic J; Bellando-Randone S; Abignano G; Avouac J; Cometi L; Czirják L; Denton CP; Distler O; Frerix M; Guiducci S; Huscher D; Jaeger VK; Lóránd V; Maurer B; Nihtyanova S; Riemekasten G; Siegert E; Tarner IH; Vettori S; Walker UA; Allanore Y; Müller-Ladner U; Del Galdo F; Matucci-Cerinic M;
Arthritis Res Ther; 2019 Jan; 21(1):35. PubMed ID: 30678703
[TBL] [Abstract][Full Text] [Related]
4. The effect of calcium channel blockers on digital ulcers in systemic sclerosis: data from a prospective cohort study.
Ross L; Hansen D; Maltez N; Morrisroe K; Kumar K; Walker J; Stevens W; Sahhar J; Ngian GS; Host L; Nikpour M; Proudman S
Clin Rheumatol; 2024 Jan; 43(1):269-276. PubMed ID: 37921914
[TBL] [Abstract][Full Text] [Related]
5. Differing commissioning arrangements may contribute to geographic variation in clinical management of digital ulcers in systemic sclerosis.
Reilly E; Alshakh R; Beynon C; Cates M; Das D; Majeed S; Memon A; O'Beirn P; Ritchie J; Pauling JD
Clin Med (Lond); 2020 May; 20(3):343-345. PubMed ID: 32414728
[TBL] [Abstract][Full Text] [Related]
6. Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review.
Ross L; Maltez N; Hughes M; Schoones JW; Baron M; Chung L; Giuggioli D; Moinzadeh P; Suliman YA; Campochiaro C; Allanore Y; Denton CP; Distler O; Frech T; Furst DE; Khanna D; Krieg T; Kuwana M; Matucci-Cerinic M; Pope J; Alunno A
Rheumatology (Oxford); 2023 Dec; 62(12):3785-3800. PubMed ID: 37335850
[TBL] [Abstract][Full Text] [Related]
7. Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis.
Bearzi P; Navarini L; Currado D; Marino A; Minerba M; Salvolini C; Perrone A; Frascà L; Liakouli V; Vomero M; Berardicurti O; Giacomelli R
Clin Exp Rheumatol; 2024 May; ():. PubMed ID: 38819960
[TBL] [Abstract][Full Text] [Related]
8. Systematic literature review to inform the Portuguese recommendations for the management of Raynaud's phenomenon and digital ulcers in systemic sclerosis and other connective tissue diseases.
Costa E; Cunha-Santos F; Dourado E; Oliveira D; Falzon L; Romão V; Duarte AC; Cordeiro A; Santiago T; Sepriano A
ARP Rheumatol; 2024 Feb; ():. PubMed ID: 38306796
[TBL] [Abstract][Full Text] [Related]
9. A patient-centered approach to the burden of symptoms in patients with scleroderma treated with Bosentan: A prospective single-center observational study.
Rezus E; Burlui AM; Gafton B; Stratulat TA; Zota GR; Cardoneanu A; Rezus C
Exp Ther Med; 2020 Mar; 19(3):1739-1746. PubMed ID: 32104228
[TBL] [Abstract][Full Text] [Related]
10. Bosentan versus nifedipine in the treatment of vasculopathy in systemic sclerosis patients: A randomized control trial.
Phat TN; Luong VH; Minh VN; My LH; Phuong HT; Vinh NTH; Doanh LH
Asian Pac J Allergy Immunol; 2022 Oct; ():. PubMed ID: 36278776
[TBL] [Abstract][Full Text] [Related]
11. Effect of Bosentan on systemic sclerosis-associated interstitial lung disease ineligible for cyclophosphamide therapy: a prospective open-label study.
Furuya Y; Kuwana M
J Rheumatol; 2011 Oct; 38(10):2186-92. PubMed ID: 21885489
[TBL] [Abstract][Full Text] [Related]
12. Longterm treatment with endothelin receptor antagonist bosentan and iloprost improves fingertip blood perfusion in systemic sclerosis.
Cutolo M; Ruaro B; Pizzorni C; Ravera F; Smith V; Zampogna G; Paolino S; Seriolo B; Cimmino M; Sulli A
J Rheumatol; 2014 May; 41(5):881-6. PubMed ID: 24692525
[TBL] [Abstract][Full Text] [Related]
13. Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis.
Hyder O; Marsh JW; Salem R; Petre EN; Kalva S; Liapi E; Cosgrove D; Neal D; Kamel I; Zhu AX; Sofocleous CT; Geschwind JF; Pawlik TM
Ann Surg Oncol; 2013 Nov; 20(12):3779-86. PubMed ID: 23846786
[TBL] [Abstract][Full Text] [Related]
14. Agreement with guidelines from a large database for management of systemic sclerosis: results from the Canadian Scleroderma Research Group.
Pope J; Harding S; Khimdas S; Bonner A; ; Baron M
J Rheumatol; 2012 Mar; 39(3):524-31. PubMed ID: 22247347
[TBL] [Abstract][Full Text] [Related]
15. Macitentan for the Treatment of Refractory Digital Ulcers in Patients With Connective Tissue Diseases.
Soto Abánades C; Noblejas Mozo A; Bonilla Hernán G; Alvarez Troncoso J; Ríos Blanco JJ
Cureus; 2023 Apr; 15(4):e38303. PubMed ID: 37255911
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of bosentan in the treatment of systemic sclerosis-related digital ulcers: Systematic review and meta-analysis.
Hosseinbalam M; Nouri R; Farajzadegan Z; Mottaghi P
J Res Med Sci; 2023; 28():3. PubMed ID: 36974107
[TBL] [Abstract][Full Text] [Related]
17. Swift and Complete Healing of Digital Ulcers after Macitentan Treatment.
Giner Serret E
Case Rep Rheumatol; 2016; 2016():1718309. PubMed ID: 27994906
[TBL] [Abstract][Full Text] [Related]
18. Management of digital vasculopathy in systemic sclerosis: benefits of multiple courses of endothelin-1 receptor antagonists.
Ngcozana T; Ong V; Denton CP
BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24682137
[TBL] [Abstract][Full Text] [Related]
19. Low occurrence of digital ulcers in scleroderma patients treated with bosentan for pulmonary arterial hypertension: a retrospective case-control study.
Cozzi F; Pigatto E; Rizzo M; Favaro M; Zanatta E; Cardarelli S; Riato L; Punzi L
Clin Rheumatol; 2013 May; 32(5):679-83. PubMed ID: 23344686
[TBL] [Abstract][Full Text] [Related]
20. Management of Raynaud's phenomenon and digital ischemia.
Herrick AL
Curr Rheumatol Rep; 2013 Jan; 15(1):303. PubMed ID: 23292819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
